A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Abroad (travel likely)RecruitingPHASE1

Conditions

Amyotrophic Lateral Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

USA004, La Jolla, California, United States
Study coordinator · rprevite@health.ucsd.edu
USA002, Palo Alto, California, United States
Study coordinator · NEUROMUSCULARRESEARCH@STANFORD.EDU
USA001, Columbia, Missouri, United States
Study coordinator · heathermchatton@health.missouri.edu
USA007, Columbus, Ohio, United States
Study coordinator · ALSResearch@osumc.edu
USA006, Philadelphia, Pennsylvania, United States
Study coordinator · Alexander.McGeary@jefferson.edu

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Amyotrophic Lateral Sclerosis (ALS)

Abroad (travel likely)RecruitingPHASE2

Scottsdale, United States · La Jolla, United States

Identification of Early Markers for ALS

Amyotrophic Lateral Sclerosis (ALS)

Abroad (travel likely)Recruiting

Tours, France

Neurologic Stem Cell Treatment Study

Neurologic Disorders · Nervous System Diseases · Neurodegenerative Diseases

Abroad (travel likely)Recruiting

Westport, United States · Coral Springs, United States

Tofersen in Non-SOD1 ALS

ALS (Amyotrophic Lateral Sclerosis)

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Boston, United States